TG Therapeutics, Inc. (TGTX)
42.86
+0.89
(+2.12%)
USD |
NASDAQ |
May 07, 09:54
TG Therapeutics SG&A Expense (TTM) : 181.70M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Precision BioSciences, Inc. | 23.69M |
| Krystal Biotech, Inc. | 114.19M |
| Catalyst Pharmaceuticals, Inc. | 171.18M |
| Geron Corp. | 119.23M |
| Viking Therapeutics, Inc. | 48.28M |